These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10562766

  • 1. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov; 36(11):86-8. PubMed ID: 10562766
    [Abstract] [Full Text] [Related]

  • 2. Reboxetine: additional benefits to the depressed patient.
    Montgomery SA.
    J Psychopharmacol; 1997 Nov; 11(4 Suppl):S9-15. PubMed ID: 9438228
    [Abstract] [Full Text] [Related]

  • 3. [Reboxetine (Edronax)].
    Souery D, Sternon J.
    Rev Med Brux; 1999 Dec; 20(6):511-6. PubMed ID: 10672775
    [Abstract] [Full Text] [Related]

  • 4. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 14():26-9. PubMed ID: 9818628
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of reboxetine in bulimia nervosa: a pilot study.
    Fassino S, Daga GA, Boggio S, Garzaro L, Pierò A.
    J Psychopharmacol; 2004 Sep; 18(3):423-8. PubMed ID: 15358988
    [Abstract] [Full Text] [Related]

  • 12. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
    Rampello L, Alvano A, Chiechio S, Raffaele R, Vecchio I, Malaguarnera M.
    Arch Gerontol Geriatr; 2005 Sep; 40(3):275-85. PubMed ID: 15814161
    [Abstract] [Full Text] [Related]

  • 13. Reboxetine in clinical practice: a review.
    Sepede G, Corbo M, Fiori F, Martinotti G.
    Clin Ter; 2012 Jul; 163(4):e255-62. PubMed ID: 23007832
    [Abstract] [Full Text] [Related]

  • 14. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
    Dubini A, Bosc M, Polin V.
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S49-55; discussion S71-3. PubMed ID: 9169310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. From symptoms to social functioning: differential effects of antidepressant therapy.
    Kasper S.
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S27-31. PubMed ID: 10468326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526675
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.
    Krell HV, Leuchter AF, Cook IA, Abrams M.
    Psychosomatics; 2005 Jul 08; 46(5):379-84. PubMed ID: 16145181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.